S
Sagun Parakh
Researcher at La Trobe University
Publications - 64
Citations - 1070
Sagun Parakh is an academic researcher from La Trobe University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 14, co-authored 46 publications receiving 688 citations. Previous affiliations of Sagun Parakh include Monash University & Ludwig Institute for Cancer Research.
Papers
More filters
Journal ArticleDOI
Outcomes of haematology/oncology patients admitted to intensive care unit at The Canberra Hospital
Sagun Parakh,A. Piggin,Teresa Neeman,Imogen Mitchell,Imogen Mitchell,Philip Crispin,Philip Crispin,Alison Davis,Alison Davis +8 more
TL;DR: Outcomes for haematology/oncology patients have improved; however, determining their suitability for intensive care unit (ICU) admission remains challenging and controversial.
Journal ArticleDOI
Molecular Imaging and Quantitation of EphA2 Expression in Xenograft Models with 89Zr-DS-8895a
Ingrid Burvenich,Sagun Parakh,Hui K Gan,Fook-Thean Lee,Nancy Guo,Angela Rigopoulos,Sze Ting Lee,Sylvia J. Gong,Graeme O'Keefe,Henri Tochon-Danguy,Masakatsu Kotsuma,Jun Hasegawa,Giorgio Senaldi,Andrew M. Scott +13 more
TL;DR: Molecular imaging of tumor uptake of DS-8895a allows noninvasive measurement of EphA2 expression in tumors in vivo and determination of receptor saturation, and is suited for human bioimaging trials on the basis of superior imaging characteristics and will inform DS- 8895a dose assessment and patient response evaluation in clinical trials.
Journal ArticleDOI
Patterns of care and outcomes for elderly patients with metastatic colorectal cancer in Australia
Sagun Parakh,Hui-Li Wong,Hui-Li Wong,Hui-Li Wong,Rajat Rai,Sayed Ali,Sayed Ali,Kathryn M. Field,Jeremy Shapiro,Rachel Wong,Louise M. Nott,Peter Gibbs,Desmond Yip,Desmond Yip +13 more
TL;DR: Chemotherapy usage and resection of metastatic disease decline with advancing age, and the cohort suggests underutilisation of bevacizumab in older patients, but where given, toxicity rates did not increase with age.
Journal ArticleDOI
Response Evaluation and Survival Prediction After PD-1 Immunotherapy in Patients with Non-Small Cell Lung Cancer: Comparison of Assessment Methods.
Narjess Ayati,Sze Ting Lee,S. Rasoul Zakavi,Melissa Cheng,W.F. Eddie Lau,Sagun Parakh,Kunthi Pathmaraj,Andrew M. Scott +7 more
TL;DR: The achieved response by all conventional and immunotherapy-modified methods correlated strongly with patients’ survival outcome, with significantly longer OS and PFS in responders than in nonresponders according to all assessed definitions.
Journal ArticleDOI
Radiolabeled Antibodies for Cancer Imaging and Therapy
TL;DR: An overview of the radiolabeled intact antibodies currently in clinical use and those in development is provided, including radioimmunoconjugates, which allows for reduced toxicity compared to conventional radiation therapy and enhances the efficacy of mAbs.